Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian clear cell adenocarcinoma: a continuing enigma.

Journal of clinical pathology - 1 Apr 2007

Tan David S P, Kaye Stan

Abstract excerpt

Ovarian clear cell adenocarcinomas (OCCAs) account for <5% of all ovarian malignancies. Compared to other epithelial ovarian cancer (EOC) subtypes, when at an advanced stage, they are associated with a poorer prognosis and are relatively resistant to conventional platinum-based chemotherapy. By c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Disease Progression
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Ovarian Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 17018684
DOI: 10.1136/jcp.2006.040030
PMCID: PMC2001101

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-17018684-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian clear cell adenocarcinoma: a continuing enigma.PMID 17018684Read ↗

Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted TherapySemantic proximity Read ↗

Translational genomics of ovarian clear cell carcinoma.Semantic proximity Read ↗

Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature ReviewSemantic proximity Read ↗

Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomicsSemantic proximity Read ↗

Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.Semantic proximity Read ↗

Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.Semantic proximity Read ↗

Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processesSemantic proximity Read ↗

Molecular characteristics and clinical behaviour of epithelial ovarian cancers.Semantic proximity Read ↗

Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.Semantic proximity Read ↗

APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis.Semantic proximity Read ↗

Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational SignaturesSemantic proximity Read ↗

Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.